Načítá se...
A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
Fenofibrate is a third-generation fibric acid derivative indicated as a monotherapy to reduce elevated low-density lipoprotein cholesterol, total cholesterol, triglycerides, and apolipoprotein B; to increase high-density lipoprotein cholesterol in patients with primary hyperlipidemia or mixed dyslip...
Uloženo v:
| Vydáno v: | Cardiol Res |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elmer Press
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5358213/ https://ncbi.nlm.nih.gov/pubmed/28352420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4021/cr270w |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|